- Home
- Publications
- Publication Search
- Publication Details
Title
The dynamics of plasma biomarkers across the Alzheimer’s continuum
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-02-08
DOI
10.1186/s13195-023-01174-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The accuracy and robustness of plasma biomarker models for amyloid PET positivity
- (2022) Andréa L. Benedet et al. Alzheimers Research & Therapy
- Racial differences in longitudinal Alzheimer's disease biomarkers among cognitively normal adults
- (2022) Chengjie Xiong et al. Alzheimers & Dementia
- Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
- (2022) Rik Ossenkoppele et al. LANCET NEUROLOGY
- Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility
- (2022) Thomas K. Karikari et al. Nature Reviews Neurology
- Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years
- (2022) Léon Beyer et al. Alzheimers & Dementia
- Application of the Amyloid/Tau/Neurodegeneration Framework in Cognitively Intact Adults: The CABLE Study
- (2022) Hao Hu et al. ANNALS OF NEUROLOGY
- Current trends in blood biomarker detection and imaging for Alzheimer’s disease
- (2022) Shun Hu et al. BIOSENSORS & BIOELECTRONICS
- Sex differences in plasma p-tau181 associations with Alzheimer’s disease biomarkers, cognitive decline, and clinical progression
- (2022) Amaryllis A. Tsiknia et al. MOLECULAR PSYCHIATRY
- Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease
- (2022) Marta Milà-Alomà et al. NATURE MEDICINE
- Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring
- (2022) Nicholas J. Ashton et al. NATURE MEDICINE
- The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease
- (2021) Joel Simrén et al. Alzheimers & Dementia
- Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology
- (2021) Nicholas J. Ashton et al. ACTA NEUROPATHOLOGICA
- Alzheimer's disease
- (2021) Philip Scheltens et al. LANCET
- A candidate biomarker of glial fibrillary acidic protein in CSF and blood in differentiating multiple sclerosis and its subtypes: A systematic review and meta-analysis
- (2021) MengJiao Sun et al. Multiple Sclerosis and Related Disorders
- Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease
- (2021) Pratishtha Chatterjee et al. Alzheimers & Dementia
- Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
- (2021) Joana B Pereira et al. BRAIN
- Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
- (2021) D. O. T. Alawode et al. JOURNAL OF INTERNAL MEDICINE
- Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
- (2021) Shorena Janelidze et al. JAMA Neurology
- Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention
- (2021) Yacoubou Abdoul Razak Mahaman et al. AGEING RESEARCH REVIEWS
- Current research status of blood biomarkers in Alzheimer’s disease: Diagnosis and prognosis
- (2021) Lei Feng et al. AGEING RESEARCH REVIEWS
- Fully automated chemiluminescence enzyme immunoassays showing high correlation with immunoprecipitation mass spectrometry assays for β-amyloid (1–40) and (1–42) in plasma samples
- (2021) Kazuto Yamashita et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
- (2021) Charlotte E Teunissen et al. LANCET NEUROLOGY
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
- (2021) Andréa L. Benedet et al. JAMA Neurology
- Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
- (2020) Carolin Heller et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia
- (2020) Shorena Janelidze et al. NATURE MEDICINE
- Temporal trajectories of in vivo tau and amyloid-β accumulation in Alzheimer’s disease
- (2020) Min Seok Baek et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts
- (2020) Thomas K Karikari et al. LANCET NEUROLOGY
- Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease
- (2020) Niklas Mattsson-Carlgren et al. Science Advances
- Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
- (2020) Marta Milà‐Alomà et al. Alzheimers & Dementia
- Sleep characteristics and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact older adults: The CABLE study
- (2020) Wei Xu et al. Alzheimers & Dementia
- The dynamics of biomarkers across the clinical spectrum of Alzheimer’s disease
- (2020) Christoforos Hadjichrysanthou et al. Alzheimers Research & Therapy
- Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration
- (2020) Alberto Benussi et al. JOURNAL OF ALZHEIMERS DISEASE
- Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative
- (2020) Thomas K. Karikari et al. MOLECULAR PSYCHIATRY
- Sequence of Alzheimer disease biomarker changes in cognitively normal adults
- (2020) Jingqin Luo et al. NEUROLOGY
- Time course of phosphorylated-tau181 in blood across the Alzheimer’s disease spectrum
- (2020) Alexis Moscoso et al. BRAIN
- Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study
- (2020) Longfei Jia et al. Lancet Public Health
- Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer’s Disease and Correlates with Cognitive Impairment
- (2019) Patrick Oeckl et al. JOURNAL OF ALZHEIMERS DISEASE
- Astrocyte Biomarkers in Alzheimer’s Disease
- (2019) Stephen F. Carter et al. TRENDS IN MOLECULAR MEDICINE
- Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
- (2019) John C. Morris et al. JAMA Neurology
- Glial Activation Markers in CSF and Serum From Patients With Primary Progressive Multiple Sclerosis: Potential of Serum GFAP as Disease Severity Marker?
- (2019) Ahmed Abdelhak et al. Frontiers in Neurology
- Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease
- (2019) Sebastian Palmqvist et al. EMBO Molecular Medicine
- Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography
- (2018) Michelle M. Mielke et al. Alzheimers & Dementia
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Race modifies the relationship between cognition and Alzheimer’s disease cerebrospinal fluid biomarkers
- (2017) Jennifer C. Howell et al. Alzheimers Research & Therapy
- Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
- (2017) Niklas Mattsson et al. JAMA Neurology
- Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
- (2016) Niklas Mattsson et al. EMBO Molecular Medicine
- CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
- (2016) Bob Olsson et al. LANCET NEUROLOGY
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Biomarker Modeling of Alzheimer’s Disease
- (2013) Clifford R. Jack et al. NEURON
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started